Increasing Compound Identification Rates in Untargeted Lipidomics Research with Liquid Chromatography Drift Time-Ion Mobility Mass Spectrometry.

Unknown metabolites represent a bottleneck in untargeted metabolomics research. Ion mobility-mass spectrometry (IM-MS) facilitates lipid identification because it yields collision cross section (CCS) information that is independent from mass or lipophilicity. To date, only a few CCS values are publicly available for complex lipids such as phosphatidylcholines, sphingomyelins, or triacylglycerides. This scarcity of data limits the use of CCS values as an identification parameter that is orthogonal to mass, MS/MS, or retention time. A combination of lipid descriptors was used to train five different machine learning algorithms for automatic lipid annotations, combining accurate mass ( m/ z), retention time (RT), CCS values, carbon number, and unsaturation level. Using a training data set of 429 true positive lipid annotations from four lipid classes, 92.7% correct annotations overall were achieved using internal cross-validation. The trained prediction model was applied to an unknown milk lipidomics data set and allowed for class 3 level annotations of most features detected in this application set according to Metabolomics Standards Initiative (MSI) reporting guidelines.

[1]  A. Simopoulos Omega-3 fatty acids in health and disease and in growth and development. , 1991, The American journal of clinical nutrition.

[2]  Michael Schroeder,et al.  LipidXplorer: A Software for Consensual Cross-Platform Lipidomics , 2012, PloS one.

[3]  R. Schneiter,et al.  Lipid signalling in disease , 2008, Nature Reviews Molecular Cell Biology.

[4]  Stephan Hann,et al.  An Interlaboratory Evaluation of Drift Tube Ion Mobility-Mass Spectrometry Collision Cross Section Measurements. , 2017, Analytical chemistry.

[5]  Min Zhou,et al.  The role of lipids in defining membrane protein interactions: insights from mass spectrometry. , 2013, Trends in cell biology.

[6]  R. Eckel,et al.  Lipids, Lipoproteins, and Cardiovascular Disease: Clinical Pharmacology Now and in the Future. , 2016, The Journal of clinical endocrinology and metabolism.

[7]  P. Carr,et al.  Instrument parameters controlling retention precision in gradient elution reversed-phase liquid. , 2014, Journal of chromatography. A.

[8]  Ilpo Vattulainen,et al.  Role of Lipids in Spheroidal High Density Lipoproteins , 2010, PLoS Comput. Biol..

[9]  R. Murphy,et al.  Tandem Mass Spectrometry in Combination with Product Ion Mobility for the Identification of Phospholipids. , 2017, Analytical chemistry.

[10]  R. Martins,et al.  The involvement of lipids in Alzheimer's disease. , 2014, Journal of genetics and genomics = Yi chuan xue bao.

[11]  M. Albrink Serum lipids, diet, and cardiovascular disease. , 1974, Postgraduate medicine.

[12]  Eoin Fahy,et al.  Template-based combinatorial enumeration of virtual compound libraries for lipids , 2012, Journal of Cheminformatics.

[13]  A. Shevchenko,et al.  Lipidomics of Human Blood Plasma by High-Resolution Shotgun Mass Spectrometry. , 2017, Methods in molecular biology.

[14]  Thomas O. Metz,et al.  LIQUID: an‐open source software for identifying lipids in LC‐MS/MS‐based lipidomics data , 2017, Bioinform..

[15]  Jeremy P. Koelmel,et al.  LipidMatch: an automated workflow for rule-based lipid identification using untargeted high-resolution tandem mass spectrometry data , 2017, BMC Bioinformatics.

[16]  I. Procino,et al.  Ion Mobility Studies on the Negative Ion-Molecule Chemistry of Isoflurane and Enflurane , 2017, Journal of The American Society for Mass Spectrometry.

[17]  O. Fiehn,et al.  LC-MS-Based Lipidomics and Automated Identification of Lipids Using the LipidBlast In-Silico MS/MS Library. , 2017, Methods in molecular biology.

[18]  Oliver Fiehn,et al.  LipidBlast - in-silico tandem mass spectrometry database for lipid identification , 2013, Nature Methods.

[19]  Zheng-Jiang Zhu,et al.  LipidCCS: Prediction of Collision Cross-Section Values for Lipids with High Precision To Support Ion Mobility-Mass Spectrometry-Based Lipidomics. , 2017, Analytical chemistry.

[20]  Biswapriya B Misra,et al.  New tools and resources in metabolomics: 2016–2017 , 2018, Electrophoresis.

[21]  R. Krauss Lipids and lipoproteins in patients with type 2 diabetes. , 2004, Diabetes care.

[22]  Masanori Arita,et al.  Identification of small molecules using accurate mass MS/MS search. , 2018, Mass spectrometry reviews.

[23]  Xianlin Han,et al.  Automated lipid identification and quantification by multidimensional mass spectrometry-based shotgun lipidomics. , 2009, Analytical chemistry.

[24]  Prabha Dwivedi,et al.  Ion mobility-mass spectrometry. , 2008, Journal of mass spectrometry : JMS.

[25]  Giuseppe Astarita,et al.  Metabolomics and lipidomics using traveling-wave ion mobility mass spectrometry , 2017, Nature Protocols.

[26]  Dieter Jahn,et al.  Comprehensive comparison of in silico MS/MS fragmentation tools of the CASMI contest: database boosting is needed to achieve 93% accuracy , 2017, Journal of Cheminformatics.

[27]  Markus R Wenk,et al.  Lipidomics: New Tools and Applications , 2010, Cell.

[28]  Yehia M. Ibrahim,et al.  Development of an Ion Mobility Spectrometry-Orbitrap Mass Spectrometer Platform. , 2016, Analytical chemistry.

[29]  H. Hong Role of Lipids in Folding, Misfolding and Function of Integral Membrane Proteins. , 2015, Advances in experimental medicine and biology.

[30]  Edward A. Mason,et al.  Mobility of gaseous lons in weak electric fields , 1958 .